3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Whooping Cough
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Solid Tumor
1
Pneumococcal Infections
1
Neoplasm Metastasis
1
Measles
1
Hepatitis B
1
HIV Infections
1
Condylomata Acuminata
1
Interventions
senaparib
7
pembrolizumab
7
Irinotecan
6
Paclitaxel
5
Docetaxel
5
Cisplatin
5
Capecitabine
5
Nivolumab
4
Fluorouracil
4
Bevacizumab
4
Rifampin
3
Midazolam
3
Leucovorin
3
Itraconazole
3
Injections
3
pertuzumab
2
ontuxizumab
2
navoximod
2
atezolizumab
2
Gemcitabine
2
vofatamab
1
tremelimumab
1
trastuzumab duocarmazine
1
talazoparib
1
sotorasib
1
sintilimab
1
saracatinib
1
rucaparib
1
ridaforolimus
1
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Solid Tumor
×
Hepatitis B Vaccines
×
Clear all
NCT02877589
2016-08-24
HepScreen
CHU de Reims
Completed
450 enrolled